Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years

Radiology

Volumn 193, Issue 2, 1994, Pages 311-314

  Feig, Stephen A ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Breast neoplasms; Breast neoplasms, diagnosis; Breast radiography; Breast radiography, quality assurance; Breast radiography, utilization; Editorials

Indexed keywords

ADULT; BREAST CANCER; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; DIAGNOSTIC VALUE; EDITORIAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMOGRAPHY; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0028099616     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.193.2.7972732     Document Type: Editorial

References (22)

1. Feig SA, Hendrick RE. Risk, benefit, and controversies in mammographic screening. In: Haus AG, Yaffe MJ, eds. Syllabus: a categorical course in physics technical aspects of breast imaging, 3rd ed. Oak Brook, Ill: Radiological Society of North America. 1994; 121-137.
2. Kopans DB, Feig SA. The National Breast Screening Study of Canada: a critical review. AJR 1993; 161:755-760.
3. Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ. A critical appraisal of the Canadian National Breast Screening Study. Radiology 1993; 189:661-663.
4. Eckhardt S, Badellino F, Murphy GP. UICC Meeting on Breast Cancer Screening in Pre-Menopausal Women in Developed Countries. Int J Cancer 1994; 56:1-5.
5. Smart CR. Highlights of the evidence of benefit for women aged 4CM9 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1994; 74:296-300.
6. Thurfjell EL, Lindgren JAA. Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala County. Radiology 1994; 193:351-357.
7. Andersson I. What can we learn from interval carcinomas? Recent Results Cancer Res 1984; 90:161-163.
8. DeGroote R, Rush BF Jr, Milazzo J, Warden MJ, Rocko JM. Interval breast cancer: a more aggressive subset of breast neoplasms. Surgery 1983; 94:543-547.
9. Frisell J, Eklund G, Hellstrom L, Somell A. Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treatment 1987; 9:219-225.
10. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986; 161:37-41.
11. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish Two-County Program of Mammographic Screening for Breast Cancer. Radiol Clin North Am 1992; 30:187-210.
12. Shapiro S, Venet W, Strax P, Venet L. Periodic Screening for Breast Cancer: the Health Insurance Plan Project and Its Sequelae, 1963-1986. Baltimore, Md: Johns Hopkins University Press, 1988.
13. Bloom NJ, Field JR. Impact of tumor grade and host resistance on survival of women with breast cancer. Cancer 1971; 28:1500-1509.
14. Milbrath JR, Moskowitz M, Bauermeister D. Breast cancer screening. CRC Crit Rev Diagn Imaging 1981; 16:181-218.
15. von Rosen A, Erhardt K, Hellstrom L, Somell A, Auer G. Assessment of malignancy potential in so-called interval mammary carcinomas. Breast Cancer Res Treatment 1985; 6:221-227.
16. Burhenne HJ, Burhenne LW, Goldberg F, et al. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification. AJR 1994; 162:1067-1071.
17. Ikeda DM, Andersson I, Wattsgard C, Janzon L, Linell F. Interval carcinomas in the Malmo Mammographic Screening Trial: radiographic appearance and prognostic considerations. AJR 1992; 159:287-294.
18. Peeters PHM, Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Vooijs GP. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 1989; 59:929-932.
19. Tabar L, Fagerberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations: an analysis based on the latest results of the Swedish two-county breast screening trial. Br J Cancer 1987; 55:547-551.
20. Kuroishi T, Tominaga S, Morimoto T. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J Cancer Res 1990; 81:454-462.
21. Peer PGM, van Dijck JAAM, Hendriks JHCL, Holland R, Verbeek ALM. Age-dependent growth rate of primary breast cancer. Cancer 1993; 71:3547-3551.
22. Pelikan S, Moskowitz M. Effects of lead time, length bias and false-negative assurance on screening for breast cancer. Cancer 1993; 71:1998-2005.